Determination of the L-Enantiomer of Nateglinide in Pharmaceutical Formulations by Micellar Electrokinetic Chromatography

다국어 초록 (Multilingual Abstract)

An analytical micellar electrokinetic chromatographic method was developed and validated for the determination of the L-enantiomer of nateglinide. Separations were carried out in a 50 μm, 64.5/56 fused-silica capillary. The optimized conditions included 75 mM borate buffer, pH 9.2, containing 50 mM of sodium dodecyl sulfate and 25 mg/mL of methyl-β-cyclodextrin as background electrolyte, an applied voltage of 20 kV and a temperature of 15, UV detector at 210 nm. The assay was validated for the L-enantiomer of nateglinide. The limit of detection and quantification were 0.07 and 0.2% respectively. Intraday precision was ranged between 0.12 and 1.7%. Interday precision ranged between 0.73 and 1.73%. The assay was applied to the determination of the L-enantiomer of nateglinide in pharmaceutical formulations.

참고문헌 (Reference)

1 Hu, S, "The mechanisms underlying the unique pharmacodynamics of nateglide" 46 (46): M37-M43, 2003

2 Keilson, L, "Synergistic Effects of Nateglinide and Meal Administration on Insulin Secretion in Patients with Type 2 Diabetes Mellitus" 85 : 1081-1086, 2000

3 Yanyan, Z, "Study of protein binding of acidic drug, nateglinide in human plasma albumin solution by high performance capillary electrophoresis/frontal analysis" 7 : 860-864, 2003

4 Li, B, "Simultaneous chiral separation of geometry isomers and enantiomers of nateglinide by capillary electrophoresis with mixture of CD derivations as chiral selector" 41 : 3177-3186, 2008

5 Bauer, S, "Rapid and simple method for the analysis of nateglinide in human plasma using HPLC analysis with UV detection" 31 : 551-555, 2003

6 Yin, J, "Rapid and efficient chiral separation of nateglinide and its L-enantiomer on monolithic molecularly imprinted polymers" 1090 : 68-75, 2005

7 Tamura, M, "Pharmacokinetics of nateglinide enantiomers and their metabolites in Goto-Kakizaki rats, a model for type 2 diabetes mellitus" 22 : 92-98, 2010

8 Walle, T, "Pharmacokinetic parameters obtained with racemates" 7 : 155-158, 1986

9 Shinkai, H, "N-(Cyclohexylcarbonyl)-D-phenylalanines and related compounds.A new oral hypoglycemic agents. 2" 32 : 1436-1441, 1989

10 Hu, S, "Interaction of nateglinide with KATP channel in β-cells underlies its unique insulinotropic action" 442 : 163-171, 2002

11 "Guideline Q2 (R1)" 2005

12 Whitelaw, D. C, "Effects of the new oral hypoglycaemic agent nateglinide on insulin secretion in type 2 diabetes mellitus" 17 : 225-229, 2000

13 Maddi, S, "Development and validation of a stereoselective HPLC method for the determination of the in vitro transport of nateglinide enantiomers in rat intestine" 30 : 1875-1880, 2007

14 Qi, M, "Determination of the LEnantiomer of Nateglinide in a Bulk Drug Substance by Chiral Reversed-Phase Liquid Chromatography" 26 : 1839-1845, 2003

15 Blanco, M, "Choice of chiral selector for enantioseparation by capillary electrophoresis" 22 : 428-439, 2003

16 Yang, G, "Chiral Separation of Nateglinide and its L Enantiomer on a Molecularly Imprinted Polymer-Based Stationary Phase" 59 : 705-708, 2004

17 Yang, G, "Chiral Separation of N-(trans-4-isopropylcyclohexylcarbonyl)-D, L-phenylalanine isomers by High Performance Liquid Chromatography" 56 : 515-518, 2002

18 Sato, H, "Analysis of enantiomers of a new antidiabetic agent in plasma by highperformance liquid chromatography" 12 : 445-455, 1989

19 Sangaraju, S, "A validated chiral LC method for the enantiomeric separation of nateglinide and the quantitative dertermination of its Lenantiomer" 69 : 1123-1127, 2009